急性心肌梗死尿激酶溶栓对住院病死率的影响

为了探讨溶栓治疗对急性心肌梗死（ＡＭＩ）急性期预后的影响，对我院１９８９年８月￣１９９７年７月收治的７８２例急性心肌梗死患者进行分析，其中尿激酶溶栓者２９７例，未溶栓者４８５便，对他们住院死率及有关影响因素作比较分析。结果表明，溶栓组与未溶栓组住院病死率分别为８．４％和１１．８％（Ｐ〉０．０５）。但溶栓再通组住院病死率（２．５％）明显低于未通组（１５．２％）（Ｐ〈０．０１）。合并严重快速心律失常和

The Effects of Urokinase Thrombolytic Therapy on in-Hospital Mortality in Patients with Acute Myocardial Infarction

In order to study the effects of thrombolytic therapy on acute prognosis in patients with acute myocardial infarction, 782 AMI cans from August 1989 to July 1997, including 297 cases using urokinase thrombolytic therapy and 485 cases no experienced thrombolysis, the in-hospital mortality and its effective factors between two groups were compared. The results showed that the in-hospital mortality of the thrombolytic group and non-thrombolytic group were 8.4 % and 11.8 % resectively(P > 0. 05 ). The mortality of reperfusion group (2.5 % ) was significantly lower than that of non-reperfusion group (15.2 % ), P < 0. 001. Moreover, the differences of mortality in patients complicated with severe tachycardia or acute pulmonary edema between reperfusion group and non-reperfusion group were still significant (P < 0 .05, P = 0. 005 ). In conclusion: Reperfusion had an independent effect on decreasing the in-hospital mortality of patients.